Everything else.. Manuri Gunawardena makes it to the Forbes ‘30 Under 30 Asia’ list

Manuri Gunawardena makes it to the Forbes ‘30 Under 30 Asia’ list

2019 Apr 4

Sri Lankan-born health tech entrepreneur, Manuri Gunawardena has made it to the Forbes ’30 Under 30 Asia’ list!
Creator, CEO, and Founder of HealthMatch, Manuri lives and works in Sydney, where her innovative startup has put her on the map. Her passion lies in bringing clinical data and digital technologies to improve the inefficiencies in delivering better healthcare.

Founded in January of 2017, HealthMatch connects people with cures and treatments around the world. The platform applies machine learning and artificial intelligence to dramatically accelerate patient recruitment to clinical trials. They aim to progress life-saving cures onto the market faster than existing practices allow. The platform has successfully raised $1.3M seed venture funding and was the winner of TechCrunch Battlefield 2017.
Manuri is a passionate believer and advocates for women in STEM, with interest in Neurosurgery, business, research and more! She studied at UNSW Australia and Harvard Business School, and has successfully completed 5 publications, winning 3 honours and awards over time!
Manuri made it to the list, and is the featured honoree under Healthcare & Science! Here’s what the Forbes list had to say about her:

“Take 25-year-old Manuri Gunawardena, founder and CEO of HealthMatch for instance. As a medical student at the University of New South, Gunawardena experienced firsthand the difficulty of finding patients to participate in trials for potentially lifesaving treatments. She also noticed there was no convenient way for patients to search for alternative treatments for their conditions. It was then, in early 2017, that she decided to play matchmaker and her startup HealthMatch was born.

Launched in Australia earlier this year, the Sydney-based startup applies machine learning to clinical data to help researchers and pharmaceutical companies find patients suitable for their studies—and vice versa. “We are automating access to clinical trials globally and dramatically improving the future of healthcare by lowering barriers to research and development,” says Gunawardena.”

Find out more about HealthMatch right here.


Please enter your comment!
Please enter your name here